Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH)

Bircan K., ÖZEN H., Ergen A., Başar I., Özgür S., Ilker Y., ...Daha Fazla

International Urology and Nephrology, cilt.22, sa.4, ss.345-348, 1990 (Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 4
  • Basım Tarihi: 1990
  • Doi Numarası: 10.1007/bf02549794
  • Dergi Adı: International Urology and Nephrology
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.345-348
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

Thirty patients with BPH were randomized into two groups to receive Raveron® and placebo for 6 weeks. The subjective and objective signs associated with BPH were evaluated before and after treatment. There was no significant difference between the effects of Raveron® and placebo. © 1990 Akadémiai Kiadó.